Summary
This randomised clinical trial examined whether a high-fibre dietary intervention could modify gut microbiota composition and downstream health outcomes in type 2 diabetes patients. The intervention increased beneficial bacteria (Lactobacillus, Bifidobacterium, Akkermansia) whilst reducing pathogenic taxa (Desulfovibrio, Klebsiella), with associated improvements in glucose homeostasis, serum metabolic profile, systemic inflammation, and emotional mood scores.
Regional applicability
The study geography is not specified in the available metadata, limiting direct applicability assessment to United Kingdom practice. If conducted in comparable healthcare settings with similar dietary patterns, findings on fibre-responsive microbiota shifts and mood improvements may be transferable to UK type 2 diabetes management; however, the generalisability depends on baseline microbiota and dietary context of the study population.
Key measures
Gut microbiota composition (16S rRNA sequencing or similar), serum metabolome profiling, systemic inflammation markers, glucose homeostasis measures, and emotional mood/psychiatric symptom scales
Outcomes reported
The study measured changes in gut microbiota composition, serum metabolome, systemic inflammation markers, and psychiatric symptoms (depression and anxiety) in type 2 diabetes patients following a high-fibre diet intervention.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.